Cargando…

Levels of Cholesterol in Small LDL Particles Predict Atherosclerosis Progression and Incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)

OBJECTIVE: Test whether angiographically-documented changes in percent stenosis and clinical endpoints (coronary-related deaths, myocardial infarctions, stroke, revascularization for worsening ischemia) in the HDL-Atherosclerosis Treatment Study (HATS) were attributable to specific LDL-subclasses. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Paul T., Zhao, Xue-Qiao, Marcovina, Santica M., Brown, B. Greg, Krauss, Ronald M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584097/ https://www.ncbi.nlm.nih.gov/pubmed/23460815 http://dx.doi.org/10.1371/journal.pone.0056782

Ejemplares similares

Associations between LDL/HDL-cholesterol ratio and thoracic and abdominal aortic atherosclerosis assessed by MRI
por: Momiyama, Yukihiko, et al.
Publicado: (2012)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2021)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

The LDL-HDL Profile Determines the Risk of Atherosclerosis: A Mathematical Model
por: Hao, Wenrui, et al.
Publicado: (2014)

Atherosclerosis, Inflammation, and Genetics - And you Thought it Was Just LDL-cholesterol
por: Gowdak, Luis Henrique Wolff
Publicado: (2020)

Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation
por: Rein, Philipp, et al.
Publicado: (2010)

Triglyceride/HDL-Cholesterol Ratio as an Index of Intracranial Atherosclerosis in Nonstroke Individuals
por: Woo, Min-Hee, et al.
Publicado: (2021)

Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
por: Wu, Zhiyuan, et al.
Publicado: (2023)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
por: Luquero, Aureli, et al.
Publicado: (2021)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
por: Srivastava, Neelam, et al.
Publicado: (2018)

HDL, Atherosclerosis, and Emerging Therapies
por: Hafiane, Anouar, et al.
Publicado: (2013)

The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration
por: Atamanalp, S. Selcuk, et al.
Publicado: (2013)

Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis
por: Zhou, Mei, et al.
Publicado: (2019)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
por: Higashi, Yukihito
Publicado: (2023)

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

Atherosclerosis: visualising oxidised LDL in zebrafish
Publicado: (2012)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Recycling the LDL receptor to combat atherosclerosis
por: Vos, Dyonne, et al.
Publicado: (2018)

HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk
por: Parra, Eliane Soler, et al.
Publicado: (2014)

ApoB and Non‐HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk
por: Johannesen, Camilla D. L., et al.
Publicado: (2022)

Differential effects of the changes of LDL cholesterol and systolic blood pressure on the risk of carotid artery atherosclerosis
por: Chien, Kuo-Liong, et al.
Publicado: (2012)

Very low levels of HDL cholesterol and atherosclerosis, a variable relationship – a review of LCAT deficiency
por: Savel, Julia, et al.
Publicado: (2012)

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol
por: Kühnast, Susan, et al.
Publicado: (2013)

Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
por: Du, Tingting, et al.
Publicado: (2017)

Rare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal
por: Alves, Ana Catarina, et al.
Publicado: (2023)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

Free Cholesterol Bioavailability and Atherosclerosis
por: Abe, Rei J., et al.
Publicado: (2022)

Discordance of Non-HDL and Directly Measured LDL Cholesterol: Which Lipid Measure is Preferred When Calculated LDL Is Inaccurate?
por: Baruch, Lawrence, et al.
Publicado: (2013)

HDL signaling and protection against coronary artery atherosclerosis in mice
por: Trigatti, Bernardo L, et al.
Publicado: (2016)

Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux
por: Navdaev, Alexei V., et al.
Publicado: (2020)

Detection of quantitative trait loci affecting serum cholesterol, LDL, HDL, and triglyceride in pigs
por: Uddin, Muhammad Jasim, et al.
Publicado: (2011)

Higher HDL cholesterol levels are associated with increased markers of interstitial myocardial fibrosis in the MultiEthnic Study of Atherosclerosis (MESA)
por: Chehab, Omar, et al.
Publicado: (2023)

P2Y13 Receptor Regulates HDL Metabolism and Atherosclerosis In Vivo
por: Goffinet, Marine, et al.
Publicado: (2014)

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
por: Kühnast, Susan, et al.
Publicado: (2015)

Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels <400 mg/dL
por: Moriyama, Kengo, et al.
Publicado: (2016)

THE EFFECT OF ALLOXAN DIABETES ON EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN THE RABBIT : I. THE INHIBITION OF EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN ALLOXAN DIABETES II. THE EFFECT OF ALLOXAN DIABETES ON THE RETROGRESSION OF EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS
por: Duff, G. Lyman, et al.
Publicado: (1949)

Periodontal Pathogens and Atherosclerosis: Implications of Inflammation and Oxidative Modification of LDL
por: Kurita-Ochiai, Tomoko, et al.
Publicado: (2014)

LDL biochemical modifications: a link between atherosclerosis and aging
por: Alique, Matilde, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kk8iuj9ckc10i01gcfpgf6ng4i